肺纤维化与肺癌:基于临床实践研究数据链与全国癌症登记数据集的分析
该研究量化了25 136例肺癌患者及250 583例匹配对照中肺纤维化(PF)的诊断比例,并比较有无PF者的肺癌自然史。结果显示肺癌患者中PF诊断更常见(1.5% vs 0.8%,OR 1.97;95%CI 1.77–2.21),PF患者鳞癌更多、腺癌更少,IV期诊断更少(OR 0.43,95%CI 0.28–0.65)但生存更差。
要点
- 肺癌患者中肺纤维化诊断比例显著高于对照人群(1.5% vs 0.8%)。
- 合并PF的肺癌患者鳞癌比例更高,腺癌比例更低。
- 合并PF者IV期诊断风险更低,但生存结局更差。
核心结论
- 肺纤维化在肺癌患者中更常见,且合并PF者虽晚期诊断较少但生存更差。
研究设计与样本
- 基于临床实践研究数据链与全国癌症登记数据集链接的回顾性分析,纳入25 136例肺癌患者和250 583例匹配对照。
主要发现
- 肺癌患者中PF诊断比例为1.5%,对照为0.8%,OR 1.97(95%CI 1.77–2.21)。
- 合并PF者中鳞状细胞癌占22.9%,无PF者为19.1%;腺癌占18.0%,无PF者为21.3%。
- 合并PF者诊断时IV期疾病风险更低(OR 0.43,95%CI 0.28–0.65),但生存更差。
临床怎么用
- 呼吸科医生应关注肺癌患者中肺纤维化的共存情况,并注意其病理类型和生存差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched controls and compared the natural history of lung cancer in people with and without PF. Diagnoses of PF were more common in people with lung cancer than those without (1.5% vs 0.8%, OR 1.97; 95% CI 1.77 to 2.21). Within people with PF, squamous cell carcinoma was more (22.9% vs 19.1%), and adenocarcinoma was less common (18.0% vs 21.3%). People with PF were less likely to have stage 4 disease at diagnosis (OR 0.43, 95% CI 0.28 to 0.65) but their survival was worse.
引用
- Gonnelli F, Kaur J, Bonifazi M, et al. Pulmonary fibrosis and lung cancer: an analysis of the Clinical Practice Research Datalink linked to the National Cancer Registration Dataset. Thorax. 2024. PMID: 39256044. doi:10.1136/thorax-2024-221865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。